Brokerages Set Smith & Nephew plc (NYSE:SNN) Target Price at $50.75

Shares of Smith & Nephew plc (NYSE:SNN) have received a consensus recommendation of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $50.75.

A number of analysts have issued reports on the stock. Commerzbank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Monday, February 22nd. Canaccord Genuity increased their price target on Smith & Nephew from $53.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, April 30th. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Smith & Nephew in a research note on Friday, May 28th. Credit Suisse Group raised shares of Smith & Nephew from a “neutral” rating to an “outperform” rating in a report on Wednesday. Finally, Barclays reiterated an “overweight” rating on shares of Smith & Nephew in a research report on Friday, April 30th.

Shares of SNN opened at $43.94 on Tuesday. The stock has a market cap of $19.31 billion, a price-to-earnings ratio of 34.06, a P/E/G ratio of 1.74 and a beta of 0.72. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.76 and a current ratio of 2.76. Smith & Nephew has a 1 year low of $34.29 and a 1 year high of $46.10. The firm’s 50 day moving average is $41.75.

A number of institutional investors have recently bought and sold shares of SNN. Nuance Investments LLC grew its position in Smith & Nephew by 7.3% in the 1st quarter. Nuance Investments LLC now owns 7,815,674 shares of the medical equipment provider’s stock valued at $296,214,000 after acquiring an additional 531,091 shares during the last quarter. WCM Investment Management LLC increased its stake in Smith & Nephew by 2.0% in the 4th quarter. WCM Investment Management LLC now owns 7,566,531 shares of the medical equipment provider’s stock worth $319,081,000 after buying an additional 146,660 shares during the period. Fiduciary Management Inc. WI lifted its holdings in Smith & Nephew by 12.5% during the 1st quarter. Fiduciary Management Inc. WI now owns 6,861,494 shares of the medical equipment provider’s stock valued at $260,051,000 after buying an additional 763,198 shares in the last quarter. Optiver Holding B.V. purchased a new stake in Smith & Nephew in the 1st quarter valued at about $126,659,000. Finally, Northern Trust Corp grew its stake in Smith & Nephew by 6.2% in the 1st quarter. Northern Trust Corp now owns 2,282,189 shares of the medical equipment provider’s stock worth $86,495,000 after acquiring an additional 132,695 shares in the last quarter. 10.45% of the stock is currently owned by institutional investors.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Featured Article: What is a Leveraged Buyout (LBO)?

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.